Scholarlink

<p>A 53-year-old woman developed edema of the extremities and Raynaud’s phenomenon 8 months before hospitalization. She was diagnosed with systemic sclerosis (SSc) and was referred to our hospital after 4 months because of rapidly progressing skin sclerosis. Treatment with prednisolone (15&#xa0;mg/day) and intermittent intravenous cyclophosphamide was initiated at the outpatient clinic of our hospital, followed by dose tapering. She was admitted to our hospital with worsening cough and dyspnea lasting 7 days. Hypertension, acute kidney injury, and signs of heart failure were observed. In addition, the features of skin sclerosis suggested scleroderma renal crisis (SRC). Blood pressure was managed with an angiotensin-converting enzyme (ACE) inhibitor, which improved the symptoms of heart failure. However, renal function did not recover, necessitating peritoneal dialysis (PD). Continued treatment with an ACE inhibitor and PD successfully controlled the hypertension, heart failure, and renal failure. Despite dialysis, rituximab therapy was administered to address the progression of skin sclerosis without significant adverse effects. Following rituximab administration, skin sclerosis and activities of daily living (ADL) significantly improved. This case highlights the efficacy of PD with an ACE inhibitor in preserving residual renal function and managing SRC. Comprehensive treatment of SSc improved complications and the patient’s ADL.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Successful treatment of scleroderma renal crisis in systemic sclerosis using angiotensin-converting enzyme inhibitor, peritoneal dialysis, and rituximab: a case report and literature review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月19日

查看全文
  • Genri Tagami,
  • Hiroshi Kinashi,
  • Kazuki Ogasawara,
  • Ai Nagashima,
  • Akimasa Asai,
  • Keisuke Kamiya,
  • Makoto Yamaguchi,
  • Shogo Banno,
  • Takuji Ishimoto,
  • Yasuhiko Ito

摘要

A 53-year-old woman developed edema of the extremities and Raynaud’s phenomenon 8 months before hospitalization. She was diagnosed with systemic sclerosis (SSc) and was referred to our hospital after 4 months because of rapidly progressing skin sclerosis. Treatment with prednisolone (15 mg/day) and intermittent intravenous cyclophosphamide was initiated at the outpatient clinic of our hospital, followed by dose tapering. She was admitted to our hospital with worsening cough and dyspnea lasting 7 days. Hypertension, acute kidney injury, and signs of heart failure were observed. In addition, the features of skin sclerosis suggested scleroderma renal crisis (SRC). Blood pressure was managed with an angiotensin-converting enzyme (ACE) inhibitor, which improved the symptoms of heart failure. However, renal function did not recover, necessitating peritoneal dialysis (PD). Continued treatment with an ACE inhibitor and PD successfully controlled the hypertension, heart failure, and renal failure. Despite dialysis, rituximab therapy was administered to address the progression of skin sclerosis without significant adverse effects. Following rituximab administration, skin sclerosis and activities of daily living (ADL) significantly improved. This case highlights the efficacy of PD with an ACE inhibitor in preserving residual renal function and managing SRC. Comprehensive treatment of SSc improved complications and the patient’s ADL.